Innovative treatment based on gene therapy is in the experimental phase. It could be a big step forward.
Russian scientists were tasked with being the first in the world to create a vaccine against aging.
The reports that Russia is developing this innovative treatment described by authorities as a possible “vaccine against aging”, based on gene therapy and still in fase experimental.
The announcement was made by those responsible for the scientific sector, who point to a potential breakthrough in the fight against cellular aging.
According to Russian Deputy Minister of Science and Higher Education, Denis Sekirinsky, the project focuses on blocking a specific receptor, known as RAGE, associated with biological processes that trigger cell aging.
When activated, this receptor contributes to the cellular deterioration; by inhibiting it, researchers believe it is possible prolong the “youth” of cells and slow the physical decline associated with age.
The treatment is being developed as a gene therapy drugwith the aim of becoming the first of its kind focused directly on slowing aging.
The research is being carried out by the Institute of Biology of Aging and Medicine, as part of a broader effort by Russia to strengthen its scientific capacity in the area of biotechnology.
This investment comes in a context of demographic challenges in the country, marked by a aging and declining population.
Russian authorities see biomedical innovation as a possible response to these trends, seeking to increase healthy life expectancy and reduce the economic impact of population aging.
Despite official enthusiasm, the project remains at an early stage and there is still no widely validated clinical data proving the efficacy or safety of the treatment in humans.
Experts emphasize that research into gene therapies applied to aging is complex and raises significant scientific and ethical questions.
